KO Client InDevR Acquired by SSI Diagnostica

KO client InDevR, a provider of advanced multiplexed solutions for vaccine testing and quality control, was recently acquired by SSI Diagnostica Group (SSID Group), a global company specializing in testing solutions for infectious diseases.

InDevR will advance SSID Group’s offering by adding recognized expertise in influenza and mRNA vaccine QC testing, and the acquisition is intended to strengthen SSID Group’s leadership in pneumococcal vaccine QC testing with next-generation multiplexing assays and enhanced customization capabilities.

“From our earliest discussions, it was clear that SSID Group was an excellent fit to advance what we have built and to provide comprehensive support for our global biopharma customers,” stated Kathy Rowlen, CEO of InDevR. “Becoming part of the company enables us to accelerate our impact so that we, together, can bring a powerful, integrated portfolio to the global vaccine and surveillance markets.”

KO partner Kevin Gibson led the deal team which included partner Matt McKinney, Of Counsel Ryan Sykora, attorneys Michael Wysolmerski and Malia Rogers, and paralegal Krystal Rushton. Read more in the announcement.